Yang Gang Tang
President chez LIVZON PHARMACEUTICAL GROUP INC.
Fortune : 2 M $ au 31/03/2024
Profil
Yang Gang Tang is currently the Chairman at Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd.
and Vice Chairman at China Association of Traditional Chinese Medicine.
He is also the Chairman at Livzon Group Xinbeijiang Pharmaceutical Manufacturing Inc. since 2008.
In addition, he holds the position of President & Executive Director at Livzon Pharmaceutical Group, Inc. since 2019 and Director at Zhuhai Livzon Diagnostics, Inc. since 2018.
Mr. Tang completed his undergraduate degree from Sichuan University in 1992.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
30/06/2023 | 344 963 ( 0,06% ) | 2 M $ | 31/03/2024 |
Postes actifs de Yang Gang Tang
Sociétés | Poste | Début |
---|---|---|
LIVZON PHARMACEUTICAL GROUP INC. | President | 20/12/2018 |
Livzon Group Xinbeijiang Pharmaceutical Manufacturing Inc.
Livzon Group Xinbeijiang Pharmaceutical Manufacturing Inc. Pharmaceuticals: OtherHealth Technology Livzon Group Xinbeijiang Pharmaceutical Manufacturing, Inc. engages in the manufacture of pharmaceutical intermediates, chemical raw materials, and additives. It also involves in research and development, and technical services. The company was founded on March 28, 1993 and is headquartered in Qingyuan, China. | Chairman | 01/07/2015 |
Zhuhai Livzon Diagnostics, Inc.
Zhuhai Livzon Diagnostics, Inc. Medical SpecialtiesHealth Technology Zhuhai Livzon Diagnostics, Inc. engages in the development, production, and marketing of in-vitro diagnostic (IVD) products. Its products include diagnostic kit for Immunoglobulin M (IgM) / Immunoglobulin G (IgG) antibody to coronavirus (SARS-CoV-2), autoimmunity multiple detection platform, chemiluminescence detection platform, nucleic acid molecule detection platform, and X-ray blood irradiator. The company was founded on January 26, 1989 and is headquartered in Zhuhai, China. | Director/Board Member | 08/11/2018 |
Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd.
Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Founded in 1979, Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd. is a subsidiary of Livzon Pharmaceutical Group, Inc. The private company is based in Fuzhou, China and manufactures and sells pharmaceutical products. | Chairman | 11/06/2014 |
China Association of Traditional Chinese Medicine | Director/Board Member | - |
Formation de Yang Gang Tang
Sichuan University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
LIVZON PHARMACEUTICAL GROUP INC. | Health Technology |
Entreprise privées | 4 |
---|---|
Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd.
Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Founded in 1979, Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd. is a subsidiary of Livzon Pharmaceutical Group, Inc. The private company is based in Fuzhou, China and manufactures and sells pharmaceutical products. | Health Technology |
China Association of Traditional Chinese Medicine | |
Livzon Group Xinbeijiang Pharmaceutical Manufacturing Inc.
Livzon Group Xinbeijiang Pharmaceutical Manufacturing Inc. Pharmaceuticals: OtherHealth Technology Livzon Group Xinbeijiang Pharmaceutical Manufacturing, Inc. engages in the manufacture of pharmaceutical intermediates, chemical raw materials, and additives. It also involves in research and development, and technical services. The company was founded on March 28, 1993 and is headquartered in Qingyuan, China. | Health Technology |
Zhuhai Livzon Diagnostics, Inc.
Zhuhai Livzon Diagnostics, Inc. Medical SpecialtiesHealth Technology Zhuhai Livzon Diagnostics, Inc. engages in the development, production, and marketing of in-vitro diagnostic (IVD) products. Its products include diagnostic kit for Immunoglobulin M (IgM) / Immunoglobulin G (IgG) antibody to coronavirus (SARS-CoV-2), autoimmunity multiple detection platform, chemiluminescence detection platform, nucleic acid molecule detection platform, and X-ray blood irradiator. The company was founded on January 26, 1989 and is headquartered in Zhuhai, China. | Health Technology |